327 related articles for article (PubMed ID: 26847311)
1. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
[TBL] [Abstract][Full Text] [Related]
2. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
Adamus G; Ren G; Weleber RG
BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune retinopathy and antiretinal antibodies: a review.
Grewal DS; Fishman GA; Jampol LM
Retina; 2014 May; 34(5):827-45. PubMed ID: 24646664
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune retinopathy with positive anti-recoverin antibodies not associated with neoplasms: Case report.
Oporto Caroca JI; Oporto Caroca J
Arch Soc Esp Oftalmol (Engl Ed); 2019 Nov; 94(11):540-544. PubMed ID: 31470998
[TBL] [Abstract][Full Text] [Related]
6. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
[TBL] [Abstract][Full Text] [Related]
7. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
[TBL] [Abstract][Full Text] [Related]
8. Slowly progressive non-neoplastic autoimmune-like retinopathy.
Ohta K; Kikuchi T; Yoshida N
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):155-8. PubMed ID: 20625760
[No Abstract] [Full Text] [Related]
9. Seroreactivity against retinal proteins in a case of POC1B gene associated cone dystrophy with normal funduscopic appearance: a systematic approach to diagnosis.
Yanık Ö; Batıoğlu F; Sahin Y; Demirel S; Özmert E
Ophthalmic Genet; 2023 Aug; 44(4):389-395. PubMed ID: 36094084
[TBL] [Abstract][Full Text] [Related]
10. Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy.
Chen FK; Chew AL; Zhang D; Chen SC; Chelva E; Chandrasekera E; Koay EMH; Forrester J; McLenachan S
Doc Ophthalmol; 2017 Jun; 134(3):227-235. PubMed ID: 28382556
[TBL] [Abstract][Full Text] [Related]
11. Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach.
Fox AR; Gordon LK; Heckenlively JR; Davis JL; Goldstein DA; Lowder CY; Nussenblatt RB; Butler NJ; Dalal M; Jayasundera T; Smith WM; Lee RW; Adamus G; Chan CC; Hooks JJ; Morgans CW; Detrick B; Sen HN
Am J Ophthalmol; 2016 Aug; 168():183-190. PubMed ID: 27210277
[TBL] [Abstract][Full Text] [Related]
12. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report.
Miura G; Baba T; Iwase T; Ohde H; Kanda A; Saito W; Ishida S; Yamamoto S
BMC Ophthalmol; 2020 Apr; 20(1):132. PubMed ID: 32252709
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated retinopathy vs recoverin-associated retinopathy.
Keltner JL; Thirkill CE
Am J Ophthalmol; 1998 Aug; 126(2):296-302. PubMed ID: 9727525
[No Abstract] [Full Text] [Related]
14. Cancer-associated retinopathy in patients with breast carcinoma.
Misiuk-Hojło M; Ejma M; Gorczyca WA; Szymaniec S; Witkowska D; Fortuna W; Miedzybrodzki R; Rogozińska-Szczepka J; Bartnik W
Arch Immunol Ther Exp (Warsz); 2007; 55(4):261-5. PubMed ID: 17659379
[TBL] [Abstract][Full Text] [Related]
15. Remission of nonparaneoplastic autoimmune retinopathy after minimal steroid treatment.
Bursztyn LL; Belrose JC; Coupland SG; Fraser JA; Proulx AA
Retin Cases Brief Rep; 2015; 9(2):173-6. PubMed ID: 25764315
[TBL] [Abstract][Full Text] [Related]
16. Hyperautofluorescent ring in autoimmune retinopathy.
Lima LH; Greenberg JP; Greenstein VC; Smith RT; Sallum JM; Thirkill C; Yannuzzi LA; Tsang SH
Retina; 2012 Jul; 32(7):1385-94. PubMed ID: 22218149
[TBL] [Abstract][Full Text] [Related]
17. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.
Lu Y; Jia L; He S; Hurley MC; Leys MJ; Jayasundera T; Heckenlively JR
Arch Ophthalmol; 2009 Dec; 127(12):1572-80. PubMed ID: 20008709
[TBL] [Abstract][Full Text] [Related]
18. [Severe visual loss caused by autoimmune retinopathy].
ten Berge JC; Schreurs MW; Dufour-van den Goorbergh BC; de Witte PM; van Schooneveld MJ; Rothova A
Ned Tijdschr Geneeskd; 2015; 159():A8039. PubMed ID: 25654680
[TBL] [Abstract][Full Text] [Related]
19. Detection of serum anti-retinal antibodies in the Chinese patients with presumed autoimmune retinopathy.
Zeng HY; Liu Q; Peng XY; Cao K; Jin SS; Xu K
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1759-1764. PubMed ID: 31119427
[TBL] [Abstract][Full Text] [Related]
20. Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung.
Dot C; Guigay J; Adamus G
Am J Ophthalmol; 2005 Apr; 139(4):746-7. PubMed ID: 15808190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
